Skip Navigation

Vaccine Safety Bibliography-January 2014

1. Estimated influenza illnesses and hospitalizations averted by influenza vaccination - United States,  2012-13 influenza season. MMWR Morb Mortal Wkly Rep. 2013 Dec 13;62 (49):997-1000.

2. Progress in immunization information systems - United States, 2012. MMWR Morb Mortal Wkly Rep. 2013 Dec 13;62(49):1005-8.

3. Rotavirus vaccines WHO position paper: January 2013 - Recommendations. Vaccine. 2013 Dec 16;31(52):6170-1.

4. Seasonal influenza vaccination coverage among women who delivered a live-born infant - 21 States and new york city, 2009-10 and 2010-11 influenza seasons. MMWR Morb Mortal Wkly Rep. 2013 Dec 13;62 (49):1001-4.

5. Vaccination coverage among persons with asthma - United States, 2010-2011 influenza season. MWR Morb Mortal Wkly Rep. 2013 Dec 6;62 (48):973-8.

6. Abramson E, Kaushal R, Vest J. Improving immunization data management: an editorial on the potential of electronic health records. Expert Rev Vaccines. 2013 Dec 18. [Epub ahead of print].

7. Adalja AA. The influenza vaccine menu. Biosecur Bioterror. 2013 Dec;11(4):235-6.

8. Adedinsewo DA, Noory L, Bednarczyk RA, Steinhoff MC, Davis R, Ogbuanu C, Omer SB. Impact of maternal characteristics on the effect of maternal influenza vaccination on fetal outcomes. Vaccine. 2013 Dec 2;31(49):5827-33.

9. Agnihothram S, Gopal R, Yount BL Jr, Donaldson EF, Menachery VD, Graham RL, Scobey TD, Gralinski LE, Denison MR, Zambon M, Baric RS. Evaluation of Serologic  and Antigenic Relationships Between Middle Eastern Respiratory Syndrome Coronavirus and Other Coronaviruses to Develop Vaccine Platforms for the Rapid Response to Emerging Coronaviruses. J Infect Dis. 2013 Dec 30. [Epub ahead of print].

10. Aibana O, Franke MF, Teng JE, Hilaire J, Raymond M, Ivers LC. Correction: Cholera Vaccination Campaign Contributes to Improved Knowledge Regarding Cholera  and Improved Practice Relevant to Waterborne Disease in Rural Haiti. PLoS Negl Trop Dis. 2013 Dec 13;7(12).

11. Al-Hello H, Jorba J, Blomqvist S, Raud R, Kew O, Roivainen M. Highly divergent type 2 and 3 vaccine-derived polioviruses isolated from sewage in Tallinn, Estonia. J Virol. 2013 Dec;87(23):13076-80.

12. Albrecht CM, Sweitzer NK, Johnson MR, Vardeny O. Lack of Persistence of Influenza Vaccine Antibody Titers in Patients with Heart Failure. J Card Fail. 2013 Dec 18. [Epub ahead of print].

13. Arencibia Jiménez M, Navarro Gracia JF, Delgado de Los Reyes JA, Pérez Torregrosa G, López Parra D, López García P. Missed Opportunities in Antipneumococcal Vaccination. Can Something More be Done for Prevention? Arch Bronconeumol. 2013 Dec 5. [Epub ahead of print].

14. Asturias EJ, Contreras-Roldan IL, Ram M, Garcia-Melgar AJ, Morales-Oquendo V, Hartman K, Rauscher M, Moulton LH, Halsey NA. Post-authorization safety surveillance of a liquid pentavalent vaccine in Guatemalan children. Vaccine. 2013 Dec 2;31(49):5909-14.

15. Auranen K, Rinta-Kokko H, Goldblatt D, Nohynek H, O'Brien KL, Satzke C, Simell B, Tanskanen A, Käyhty H; Pneumococcal Carriage Group (PneumoCarr). Colonisation endpoints in Streptococcus pneumoniae vaccine trials. Vaccine. 2013 Dec 17;32(1):153-8.

16. Auranen K, Rinta-Kokko H, Goldblatt D, Nohynek H, O'Brien KL, Satzke C, Simell B, Tanskanen A, Käyhty H. Design questions for Streptococcus pneumonia vaccine trials with a colonisation endpoint. Vaccine. 2013 Dec 17;32(1):159-64.

17. Azevedo LS, Gerhard J, Miraglia JL, Precioso AR, Tavares Timenetsky MD, Agena F, Gamba C, Shikanai Yasuda MA, David-Neto E, Pierrotti L. Seroconversion of 2009 pandemic influenza A (H1N1) vaccination in kidney transplant patients and the influence of different risk factors. Transpl Infect Dis. 2013 Dec;15(6):612-8.

18. Azizi A, Tang M, Gisonni-Lex L, Mallet L. Evaluation of infectious titer in a candidate HSV type 2 vaccine by a quantitative molecular approach. BMC Microbiol. 2013 Dec 6;13:284.

19. Azmi F, Ahmad Fuaad AA, Skwarczynski M, Toth I. Recent progress in adjuvant discovery for peptide-based subunit vaccines. Hum Vaccin Immunother. 2013 Dec 3;10(3). [Epub ahead of print].

20. Bairwa M, Pilania M, Gupta V, Yadav K. Hypertension Vaccine may be a boon to millions in developing world. Hum Vaccin Immunother. 2013 Dec 23;10(4). [Epub ahead of print].

21. Barker CI, Snape MD. Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action. Lancet Infect Dis. 2013 Dec 18. [Epub ahead of print].

22. Bell RA, McGlone MS, Dragojevic M. Vicious Viruses and Vigilant Vaccines: Effects of Linguistic Agency Assignment in Health Policy Advocacy. J Health Commun. 2013 Dec 19. [Epub ahead of print].

23. Belshe RB, Heineman TC, Bernstein DI, Bellamy AR, Ewell M, van der Most R, Deal CD. Correlate of Immune Protection Against HSV-1 Genital Disease in Vaccinated Women. J Infect Dis. 2013 Dec 29. [Epub ahead of print].

24. Beyer WE, McElhaney J, Smith DJ, Monto AS, Nguyen-Van-Tam JS, Osterhaus AD. Cochrane re-arranged: Support for policies to vaccinate elderly people against influenza. Vaccine. 2013 Dec 5;31(50):6030-3.

25. Bhattacharya SK, Sur D, Ali M, Kanungo S, You YA, Manna B, Sah B, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Dhingra MS, Donner A, Nair GB, Lopez AL, Wierzba TF, Clemens JD. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2013 Dec;13(12):1050-6.

26. Black S. The role of health economic analyses in vaccine decision making. Vaccine. 2013 Dec 9;31(51):6046-9.

27. Boltin D, Gingold-Belfer R, Kimchi NA, Ben-Bassat O, Niv Y, Birkenfeld S. Utilization of Influenza Immunization in Adults with Crohn's Disease-A Longitudinal, Population-Based Study. Inflamm Bowel Dis. 2013 Dec 26. [Epub ahead of print].

28. Bonfiglioli R, Vignoli M, Guglielmi D, Depolo M, Violante FS. Getting vaccinated or not getting vaccinated?: different reasons for getting vaccinated against seasonal or pandemic influenza. BMC Public Health. 2013 Dec 21;13(1):1221. [Epub ahead of print].

29. Bottomley C, Roca A, Hill PC, Greenwood B, Isham V. A mathematical model of serotype replacement in pneumococcal carriage following vaccination. J R Soc Interface. 2013 Oct 16;10(89):20130786.

30. Bourdette D, Naismith RT. BCG vaccine for clinically isolated syndrome and MS: Infections and protective immunity. Neurology. 2014 Jan 7;82(1):15-6.

31. Brotherton JM, Liu B, Donovan B, Kaldor JM, Saville M. Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: Independent estimates from a nationally representative mobile phone survey. Vaccine. 2013 Dec 5. [Epub ahead of print].

32. Bushardt RL, Winter M. Are immunizations safe and effective for patients being treated with immunosuppressive agents? JAAPA. 2013 Dec;26(12):12-3.

33. Calhoun LM, van Eijk AM, Lindblade KA, Odhiambo FO, Wilson ML, Winterbauer E, Slutsker L, Hamel MJ. Determinants and Coverage of Vaccination in Children in Western Kenya from a 2003 Cross-Sectional Survey. Am J Trop Med Hyg. 2013 Dec 16. [Epub ahead of print].

34. Campbell CT, Llewellyn SR, Demberg T, Morgan IL, Robert-Guroff M, Gildersleeve JC. Correction: High-Throughput Profiling of Anti-Glycan Humoral Responses to SIV Vaccination and Challenge. PLoS One. 2013 Dec 3;8(12).

35. Cassone A. Development of vaccines for Candida albicans: fighting a skilled transformer. Nat Rev Microbiol. 2013 Dec;11(12):884-91.

36. Caum J, Alles S. Ready or not: analysis of a no-notice mass vaccination field response in Philadelphia. Biosecur Bioterror. 2013 Dec;11(4):262-70.

37. Chan TC, Fan-Ngai Hung I, Ka-Hay Luk J, Chu LW, Hon-Wai Chan F. Effectiveness of Influenza Vaccination in Institutionalized Older Adults: A Systematic Review. J Am Med Dir Assoc. 2013 Dec 6. [Epub ahead of print].

38. Chan TC, Fan-Ngai Hung I, Ka-Hay Luk J, Chiu-Yat Woo P, Chu LW, Hon-Wai Chan  F. Efficacy of trivalent seasonal influenza vaccination in reducing mortality and hospitalization in chinese nursing home older adults. J Am Med Dir Assoc. 2013 Dec;14(12):889-94.

39. Chlibek R, Bayas JM, Collins H, de la Pinta ML, Ledent E, Mols JF, Heineman TC. Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults >=50 Years of Age. J Infect Dis. 2013 Dec; 208(12):1953-61.

40. Collard JM, Issaka B, Zaneidou M, Hugonnet S, Nicolas P, Taha MK, Greenwood B, Jusot JF. Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination. BMC Infect Dis. 2013 Dec 6;13:576.

41. Collins DA, Hoskins A, Bowman J, Jones J, Stemberger NA, Richmond PC, Leach AJ, Lehmann D. High nasopharyngeal carriage of non-vaccine serotypes in Western Australian aboriginal people following 10 years of pneumococcal conjugate vaccination. PLoS One. 2013 Dec 3;8(12):e82280.

42. Cornish KE, de Villiers SH, Pravetoni M, Pentel PR. Immunogenicity of individual vaccine components in a bivalent nicotine vaccine differ according to  vaccine formulation and administration conditions. PLoS One. 2013 Dec 2;8(12):e82557.

43. Cortes-Penfield N. Mandatory Influenza Vaccination for Health Care Workers as the New Standard of Care: A Matter of Patient Safety and Nonmaleficent Practice.  Am J Public Health. 2013 Dec 12. [Epub ahead of print].

44. Crawford NW, Clothier H, Hodgson K, Selvaraj G, Easton ML, Buttery JP. Active surveillance for adverse events following immunization. Expert Rev Vaccines. 2013 Dec 18. [Epub ahead of print].

45. Cromer D, van Hoek AJ, Jit M, Edmunds WJ, Fleming D, Miller E. The burden of influenza in England by age and clinical risk group: A statistical analysis to inform vaccine policy. J Infect. 2013 Dec 1. [Epub ahead of print].

46. Cruzeta AP, Schneider IJ, Traebert J. Impact of seasonality and annual immunization of elderly people upon influenza-related hospitalization rates. Int  J Infect Dis. 2013 Dec;17(12):e1194-7.

47. Curran EA, Seib KG, Wells K, Hannan C, Bednarczyk RA, Hinman AR, Omer SB. A National Survey of Immunization Programs Regarding Immunization Information Systems Data Sharing and Use. J Public Health Manag Pract. 2013 Dec 27. [Epub ahead of print].

48: Daniels CC, Shelton CM, Bass PJ, Wang WC, Suda KJ. Limb swelling in a pediatric sickle cell patient after revaccination with pneumococcal vaccine. Int J Clin Pharm. 2013 Dec 5. [Epub ahead of print].

49. Davis SM, Deloria-Knoll M, Kassa HT, O'Brien KL. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: Review of evidence on indirect effects. Vaccine. 2013 Dec 17;32(1):133-45.

50. Dayan GH, Garbes P, Noriega F, Izoton de Sadovsky AD, Rodrigues PM, Giuberti  C, Dietze R. Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9-16 years in Brazil. Am J Trop Med Hyg. 2013 Dec;89(6):1058-65.

51. de Assis FL, Vinhote WM, Barbosa JD, de Oliveira CH, de Oliveira CM, Campos KF, Silva NS, Trindade Gde S; Jônatas. Reemergence of Vaccinia Virus during Zoonotic Outbreak, Pará State, Brazil. Emerg Infect Dis. 2013 Dec;19(12):2017-20.

52. de Oliveira Lopes D, de Oliveira FM, do Vale Coelho IE, de Oliveira Santana KT, Mendonça FC, Taranto AG, Dos Santos LL, Miyoshi A, de Carvalho Azevedo VA, Comar M Jr. Identification of a vaccine against schistosomiasis using bioinformatics and molecular modeling tools. Infect Genet Evol. 2013 Dec;20:83-95.

53. de Souto Barreto P, Lapeyre-Mestre M, Vellas B, Rolland Y. Indicators of influenza and pneumococcal vaccination in French nursing home residents in 2011. Vaccine. 2013 Dec 23. [Epub ahead of print].

54. de Souza IM, da Silva MN, Figueira ES, de Lourdes Leal M, Jessouroun E, de Mello Pereira Abrantes S, da Silveira IA. Single validation of CE method for determining free polysaccharide content in a Brazilian meningococcal C conjugate  vaccine. Electrophoresis. 2013 Dec;34(22-23):3221-6.

55. de Villiers SH, Cornish KE, Troska AJ, Pravetoni M, Pentel PR. Increased efficacy of a trivalent nicotine vaccine compared to a dose-matched monovalent vaccine when formulated with alum. Vaccine. 2013 Dec 16;31(52):6185-93.

56. Debin M, Colizza V, Blanchon T, Hanslik T, Turbelin C, Falchi A. Effectiveness of 2012-2013 influenza vaccine against influenza-like illness in general population: Estimation in a French web-based cohort. Hum Vaccin Immunother. 2013 Dec 16;10(3). [Epub ahead of print].

57. Dellepiane N, Wood D. Twenty-five years of the WHO vaccines prequalification programme (1987-2012): Lessons learned and future perspectives. Vaccine. 2013 Dec 2. pii: S0264-410X(13)01628-9. [Epub ahead of print].

58. Demczuk WH, Martin I, Griffith A, Lefebvre B, McGeer A, Lovgren M, Tyrrell GJ, Desai S, Sherrard L, Adam H, Gilmour M, Zhanel GG; Toronto Bacterial Diseases Network; Canadian Public Health Laboratory Network. Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012. Can J Microbiol. 2013 Dec;59(12):778-88.

59. Denis F, Cohen R, Stahl JP, Martinot A, Dury V, Le Danvic M, Gaudelus J. Papillomavirus vaccination in France according to 2008 to 2012 Vaccinoscopie(®) data. Med Mal Infect. 2013 Dec 4. [Epub ahead of print].

60. Dhédin N, Krivine A, Le Corre N, Mallet A, Lioure B, Bay JO, Rubio MT, Agape  P, Thiébaut A, Le Goff J, Autran B, Ribaud P. Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients. Vaccine. 2013 Dec 12. [Epub ahead of print].

61. Di Pilato M, Mejías-Pérez E, Gómez CE, Perdiguero B, Sorzano CO, Esteban M. New vaccinia virus promoter as a potential candidate for future vaccines. J Gen Virol. 2013 Dec;94(Pt 12):2771-6.

62. Diedrichs DR, Isihara PA, Buursma DD. The schedule effect: Can recurrent peak infections be reduced without vaccines, quarantines or school closings? Math Biosci. 2013 Dec 19. [Epub ahead of print].

63. Diekema DS. Personal Belief Exemptions From School Vaccination Requirements. Annu Rev Public Health. 2013 Dec 11. [Epub ahead of print].

64. Dimitriou TG, Pliaka V, Kyriakopoulou Z, Ruether IG, Tsakogiannis D, Fountoucidou P, Gartzonika C, Levidiotou-Stefanou S, Markoulatos P. PCR assays for the identification of rare recombination types from VP1 to 3D genomic region  of vaccine derived poliovirus strains. Mol Cell Probes. 2013 Dec 4. [Epub ahead of print].

65. Djuardi Y, Sartono E, Wibowo H, Supali T, Yazdanbakhsh M. Correction: A Longitudinal Study of BCG Vaccination in Early Childhood: The Development of Innate and Adaptive Immune Responses. PLoS One. 2013 Dec 17;8(12).

66. Domenech M, Araújo L, García E, Moscoso M. In vitro biofilm formation by Streptococcus pneumoniae as a predictor of post-vaccination emerging serotypes colonizing the human nasopharynx. Environ Microbiol. 2013 Dec 24. [Epub ahead of print].

67. Dos Santos SR, Passadore LF, Takagi EH, Fujii CM, Yoshioka CR, Gilio AE, Martinez MB. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation. Vaccine. 2013 Dec 9;31(51):6150-4.

68. Durviaux S, Treanor J, Beran J, Duval X, Esen M, Feldman G, Frey SE, Launay O, Leroux-Roels G, McElhaney JE, Nowakowski A, Ruiz-Palacios GM, van Essen GA, Oostvogels L, Devaster JM, Walravens K. Genetic and antigenic typing of seasonal  influenza breakthrough cases from a 2008-2009 vaccine efficacy trial. Clin Vaccine Immunol. 2013 Dec 26. [Epub ahead of print].

69. Elemraid MA, Sails AD, Eltringham GJ, Perry JD, Rushton SP, Spencer DA, Thomas MF, Eastham KM, Hampton F, Gennery AR, Clark JE; North East of England Paediatric Respiratory Infection Study Group. Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine. Eur Respir J. 2013 Dec;42(6):1595-603.

70. Elias SC, Choudhary P, de Cassan SC, Biswas S, Collins KA, Halstead FD, Bliss CM, Ewer KJ, Hodgson SH, Duncan CJ, Hill AV, Draper SJ. Analysis of Human B cell  Responses following ChAd63-MVA MSP1 and AMA1 Immunization and Controlled Malaria Infection. Immunology. 2013 Dec 5. [Epub ahead of print].

71. Esposito S, Principi N, Cornaglia G; The ESCMID Vaccine Study Group (EVASG).  Barriers To The Vaccination Of Children And Adolescents And Possible Solutions. Clin Microbiol Infect. 2013 Dec 19. [Epub ahead of print].

72. Estrella-Tec JE, Gutiérrez-Ruiz EJ, Ramírez-González S, Aranda-Cirerol F, Santos-Ricalde R, Puerto-Nájera JL. Evaluation of a commercial vaccine against avian poxvirus in turkeys kept in the backyard system in the state of Yucatan, Mexico. Avian Pathol. 2013 Dec;42(6):536-40.

73. Fell DB, Dodds L, MacDonald NE, Allen VM, McNeil S. Influenza vaccination and fetal and neonatal outcomes. Expert Rev Vaccines. 2013 Dec;12(12):1417-30.

74. Filì L, Cardilicchia E, Maggi E, Parronchi P. Perspectives in vaccine adjuvants for allergen-specific immunotherapy. Immunol Lett. 2013 Dec 19. [Epub ahead of print].

75. Fink K, Shi PY. Live attenuated vaccine: the first clinically approved dengue vaccine? Expert Rev Vaccines. 2013 Dec 18. [Epub ahead of print].

76. Fontenot HB, Fantasia HC, Charyk A, Sutherland MA. Human Papillomavirus (HPV) Risk Factors, Vaccination Patterns, and Vaccine Perceptions Among a Sample of Male College Students. J Am Coll Health. 2013 Dec 12. [Epub ahead of print].

77. Freed DC, Tang Q, Tang A, Li F, He X, Huang Z, Meng W, Xia L, Finnefrock AC,  Durr E, Espeseth AS, Casimiro DR, Zhang N, Shiver JW, Wang D, An Z, Fu TM. Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine. Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):E4997-5005.

78. Frère J, De Wals P, Ovetchkine P, Coïc L, Audibert F, Tapiero B. Evaluation of several approaches to immunize parents of neonates against B. pertussis. Vaccine. 2013 Dec 9;31(51):6087-91.

79. Fujiwara H, Takei Y, Ishikawa Y, Saga Y, Machida S, Taneichi A, Suzuki M. Community-Based Interventions to Improve HPV Vaccination Coverage among 13- to 15-Year-Old Females: Measures Implemented by Local Governments in Japan. PLoS One. 2013 Dec 16;8(12):e84126.

80. Fung HM, Mikasa TJ, Vergara J, Sivananthan SJ, Guderian JA, Duthie MS, Vedvick TS, Fox CB. Optimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activity. J Nanobiotechnology. 2013 Dec 21;11(1):43. [Epub ahead of print].

81. Furman D, Hejblum BP, Simon N, Jojic V, Dekker CL, Thiébaut R, Tibshirani RJ, Davis MM. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci U S A. 2013 Dec 23. [Epub ahead of print].

82. Gaglani M, Spencer S, Ball S, Song J, Naleway A, Henkle E, Bozeman S, Reynolds S, Sessions W, Hancock K, Thompson M. Antibody response to influenza A (H1N1)pdm09 among healthcare personnel receiving trivalent inactivated vaccine: effect of prior monovalent inactivated vaccine. J Infect Dis. 2013 Dec 19. [Epub  ahead of print].

83. Galen JE, Curtiss R 3rd. The delicate balance in genetically engineering live vaccines. Vaccine. 2013 Dec 23. [Epub ahead of print].

84. Gautam R, Esona MD, Mijatovic-Rustempasic S, Ian Tam K, Gentsch JR, Bowen MD. Real-time RT-PCR assays to differentiate wild-type group A rotavirus strains from Rotarix(®) and RotaTeq(®) vaccine strains in stool samples. Hum Vaccin Immunother. 2013 Dec 16;10(3). [Epub ahead of print].

85. Gefenaite G, Rahamat-Langendoen J, Ambrozaitis A, Mickiene A, Jancoriene L, Kuliese M, Velyvyte D, Niesters H, Stolk RP, Zagminas K, Hak E. Seasonal influenza vaccine effectiveness against influenza in 2012-2013: A hospital-based  case-control study in Lithuania. Vaccine. 2013 Dec 23. [Epub ahead of print].

86. Gelman A, Miller E, Schwarz EB, Akers AY, Jeong K, Borrero S. Racial disparities in human papillomavirus vaccination: does access matter? J Adolesc Health. 2013 Dec;53(6):756-62.

87. Ghinai I, Willott C, Dadari I, Larson HJ. Listening to the rumours: What the northern Nigeria polio vaccine boycott can tell us ten years on. Glob Public Health. 2013 Dec;8(10):1138-50.

88. Giambrone GP, Zansky SM, Eidson M, Duncan PG, McNutt LA, Birkhead GS. Guillain-Barré Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009. Emerg Infect Dis. 2013 Dec;19(12):1956-62.

89. Gilchrist SA, Nanni A. Lessons learned in shaping vaccine markets in low-income countries: a review of the vaccine market segment supported by the GAVI Alliance. Health Policy Plan. 2013 Dec;28(8):838-46.

90. Goldman G, King P. Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data. Hum Exp Toxicol. 2013 Dec 10. [Epub ahead of print].

91. Gong K, Tang M, Hui PM, Zhang HF, Younghae D, Lai YC. An efficient immunization strategy for community networks. PLoS One. 2013 Dec 20;8(12):e83489.

92. Goren A, Roberts C, Victor TW. Comorbid risk, respondent characteristics and likelihood of pneumococcal vaccination versus no vaccination among older adults in Brazil. Expert Rev Vaccines. 2013 Dec 4. [Epub ahead of print].

93. Gorse GJ, Falsey AR, Johnson CM, Morrison D, Fried DL, Ervin JE, Greenberg DP, Ozol-Godfrey A, Landolfi V, Tsang PH. Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18-64 years of age. Vaccine. 2013 Dec 5;31(50):6034-40. 

94. Gounder PP, Bruce MG, Bruden DJ, Singleton RJ, Rudolph K, Hurlburt DA, Hennessy TW, Wenger J. Effect of the 13-Valent Pneumococcal Conjugate Vaccine on  Nasopharyngeal Colonization by Streptococcus pneumoniae--Alaska, 2008-2012. J Infect Dis. 2013 Dec 29. [Epub ahead of print].

95. Grabenstein JD, Weber DJ. Pneumococcal Serotype Diversity among Adults in Various Countries, Influenced by Pediatric Pneumococcal Vaccination Uptake. Clin Infect Dis. 2013 Dec 15. [Epub ahead of print].

96. Grabiel M, Reutzel TJ, Wang S, Rubin R, Leung V, Ordonez A, Wong M, Jordan E. HPV and HPV vaccines: the knowledge levels, opinions, and behavior of parents. J Community Health. 2013 Dec;38(6):1015-21.

97. Gualberto FA, de Oliveira MI, Alves VA, Kanamura CT, Rosemberg S, Sato HK, Arantes BA, Curti SP, Figueiredo CA. Fulminant encephalitis associated with a vaccine strain of rubella virus. J Clin Virol. 2013 Dec; 58(4):737-40.

98. Haidari LA, Connor DL, Wateska AR, Brown ST, Mueller LE, Norman BA, Schmitz  MM, Paul P, Rajgopal J, Welling JS, Leonard J, Chen SI, Lee BY. Correction: Augmenting Transport versus Increasing Cold Storage to Improve Vaccine Supply Chains. PLoS One. 2013 Dec 10; 8(12).

99. Hale SF, Camaione L, Lomaestro BM. MenHibrix: A New Combination Meningococcal Vaccine for Infants and Toddlers. Ann Pharmacother. 2013 Dec 18. [Epub ahead of print].

100. Hales CM, Harpaz R, Joesoef MR, Bialek SR. Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann Intern Med. 2013 Dec 3;159(11):739-45.

101. Hallander H, Advani A, Alexander F, Gustafsson L, Ljungman M, Pratt C, Hall  I, Gorringe AR. Antibody responses in Sweden to individual Bordetella pertussis fimbriae serotype 2 or 3 following immunization with whole cell or two- or five-component acellular pertussis vaccines and following pertussis disease and in children in 1997 and 2007. Clin Vaccine Immunol. 2013 Dec 4. [Epub ahead of print].

102. Halsey NA, Griffioen M, Dreskin SC, Dekker CL, Wood R, Sharma D, Jones JF, Larussa PS, Garner J, Berger M, Proveaux T, Vellozzi C; Hypersensitivity Working  Group of the Clinical Immunization Safety Assessment Network. Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: Reports to VAERS. Vaccine. 2013 Dec 9;31(51):6107-12.

103. Hanf M, Quantin C, Farrington P, Benzenine E, Hocine NM, Velten M, Tubert-Bitter P, Escolano S. Validation of the French national health insurance information system as a tool in vaccine safety assessment: Application to febrile convulsions after pediatric measles/mumps/rubella immunization. Vaccine. 2013 Dec 2;31(49):5856-62.

104. Haque R, Snider C, Liu Y, Ma JZ, Liu L, Nayak U, Mychaleckyj JC, Korpe P, Mondal D, Kabir M, Alam M, Pallansch M, Oberste MS, Weldon W, Kirkpatrick BD, Petri WA Jr. Oral polio vaccine response in breast fed infants with malnutrition and diarrhea. Vaccine. 2013 Dec 2. [Epub ahead of print].

105. Hara M, Okada K, Yamaguchi Y, Uno S, Otsuka Y, Shimanoe C, Nanri H, Horita M, Ozaki I, Nishida Y, Tanaka K. Immunogenicity and safety after booster vaccination of diphtheria, tetanus, and acellular pertussis in young adults: an open randomized controlled trial in Japan. Clin Vaccine Immunol. 2013 Dec;20(12):1799-804.

106. Harmsen IA, Doorman GG, Mollema L, Ruiter RA, Kok G, de Melker HE. Parental information-seeking behaviour in childhood vaccinations. BMC Public Health. 2013 Dec 21;13(1):1219. [Epub ahead of print].

107. Harmsen IA, Mollema L, Ruiter RA, Paulussen TG, de Melker HE, Kok G. Why parents refuse childhood vaccination: a qualitative study using online focus groups. BMC Public Health. 2013 Dec 16;13(1):1183.

108. Hawken S, Kwong JC, Deeks SL, Crowcroft NS, Ducharme R, Manuel DG, Wilson K. Association between Birth Order and Emergency Room Visits and Acute Hospital Admissions following Pediatric Vaccination: A Self-Controlled Study. PLoS One. 2013 Dec 4;8(12):e81070.

109. Hayford KT, Shomik MS, Al-Emran HM, Moss WJ, Bishai D, Levine OS. Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood: a population-based cross-sectional study. BMC Public Health. 2013 Dec 20;13(1):1211. [Epub ahead of print].

110. Heard I, Floret D. [Age for HPV vaccination: recommandations from the French high council of public health]. Med Sci (Paris). 2013 Dec;29(12):1161-6.

111. Hemming M, Vesikari T. Detection of Rotateq® Vaccine-Derived Double Reassortant Rotavirus in a 7-Year-Old Child with Acute Gastroenteritis. Pediatr Infect Dis J. 2013 Dec 9. [Epub ahead of print].

112. Hendrickson BK, Panchanathan SS, Petitti D. Evaluation of Immunization Data Completeness Within a Large Community Health Care System Exchanging Data With a State Immunization Information System. J Public Health Manag Pract. 2013 Dec 27. [Epub ahead of print].

113. Hilyard KM, Quinn SC, Kim KH, Musa D, Freimuth VS. Determinants of Parental Acceptance of the H1N1 Vaccine. Health Educ Behav. 2013 Dec 25. [Epub ahead of print].

114. Hollm-Delgado MG, Stuart EA, Black RE. Acute Lower Respiratory Infection Among Bacille Calmette-Guerin (BCG)-Vaccinated Children. Pediatrics. 2013 Dec 30.[Epub ahead of print].

115. Howie SR, Oluwalana C, Secka O, Scott S, Ideh RC, Ebruke BE, Balloch A, Sambou S, Erskine J, Lowe Y, Corrah T, Adegbola RA. The effectiveness of conjugate Haemophilus influenzae type B vaccine in The Gambia 14 years after introduction. Clin Infect Dis. 2013 Dec;57(11):1527-34.

116. Hss AS, Koh MT, Tan KK, Chan LG, Zhou L, Bouckenooghe A, Crevat D, Hutagalung Y. Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2-11 years in Malaysia: A randomized, placebo-controlled, Phase III study. Vaccine. 2013 Dec 2;31(49):5814-21.

117. Hu YM, Wang X, Wang JZ, Wang L, Zhang YJ, Chang L, Liang ZL, Xia JL, Dai QG, Hu YL, Mao QY, Zhu FC, Song YF, Gao F, Chen JT. Immunogenicity, safety, and lot consistency of a novel inactivated enterovirus 71 vaccine in chinese children aged 6 to 59 months. Clin Vaccine Immunol. 2013 Dec;20(12):1805-11.

118. Hua C, Barnetche T, Combe B, Morel J. Effect of methotrexate, anti-TNFα and  rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: A systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2013 Dec 10. [Epub ahead of print].

119. Imaz I, Rubio B, Cornejo AM, González-Enríquez J. Budget impact and cost-utility analysis of universal infant rotavirus vaccination in Spain. Prev Med. 2013 Dec 18. [Epub ahead of print].

120. Iqbal S, Barile JP, Thompson WW, Destefano F. Number of antigens in early childhood vaccines and neuropsychological outcomes at age 7-10 years. Pharmacoepidemiol Drug Saf. 2013 Dec;22(12):1263-70.

121. Ishola DA Jr, Permalloo N, Cordery RJ, Anderson SR. Midwives' influenza vaccine uptake and their views on vaccination of pregnant women. J Public Health (Oxf). 2013 Dec;35(4):570-7.

122. Jaiswal V, Chauhan RS, Rout C. Common antigens prediction in bacterial bioweapons: A perspective for vaccine design. Infect Genet Evol. 2013 Dec 1; 21C:315-319. [Epub ahead of print].

123. James EA, LaFond RE, Gates TJ, Mai DT, Malhotra U, Kwok WW. Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins. J Virol. 2013 Dec;87(23):12794-804.

124. Jeannot E, Wyler CA, Meynard A, Kaiser B, Sudre P, Alvarin J, Chastonay P. [Factors associated with HPV immunization for 13-14-year-old girls in the Geneva district, Switzerland]. Rev Epidemiol Sante Publique. 2013 Dec;61(6):513-8.

125. Johnson MG, Bradley KK, Mendus S, Burnsed L, Clinton R, Tiwari T. Vaccine-preventable disease among homeschooled children: two cases of tetanus in oklahoma. Pediatrics. 2013 Dec;132(6):e1686-9.

126. Jones C, Pollock L, Barnett SM, Battersby A, Kampmann B. The relationship between concentration of specific antibody at birth and subsequent response to primary immunization. Vaccine. 2013 Dec 13. [Epub ahead of print].

127. Jutel M, Van de Veen W, Agache I, Azkur KA, Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development. Allergol  Int. 2013 Dec;62(4):425-33.

128. Khan IA, Saha A, Chowdhury F, Khan AI, Uddin MJ, Begum YA, Riaz BK, Islam S, Ali M, Luby SP, Clemens JD, Cravioto A, Qadri F. Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh. Vaccine. 2013 Dec 9;31(51):6058-64.

129. Kilpatrick DR, Ching K, Iber J, Chen Q, Yang SJ, De L, Williams AJ, Mandelbaum M, Sun H, Oberste MS, Kew OM. Identification of vaccine-derived polioviruses using dual-stage real-time RT-PCR. J Virol Methods. 2013 Dec 7;197C:25-28. [Epub ahead of print].

130. Knerer G, Currie CS, Brailsford SC. Impact of combined vector-control and vaccination strategies on transmission dynamics of dengue fever: a model-based analysis. Health Care Manag Sci. 2013 Dec 27. [Epub ahead of print].

131. Kobayashi H, Iwatsuki-Horimoto K, Kiso M, Uraki R, Ichiko Y, Takimoto T, Kawaoka Y. A replication-incompetent influenza virus bearing the HN glycoprotein  of human parainfluenza virus as a bivalent vaccine. Vaccine. 2013 Dec 16;31(52):6239-46.

132. Kochhar S, Rath B, Seeber LD, Rundblad G, Khamesipour A, Ali M; Vienna Vaccine Safety Initiative. Introducing new vaccines in developing countries. Expert Rev Vaccines. 2013 Dec;12(12):1465-78.

133. Kramer RM, Zeng Y, Sahni N, Kueltzo LA, Schwartz RM, Srivastava IK, Crane L, Joshi SB, Volkin DB, Middaugh CR. Development of a Stable Virus-Like Particle Vaccine Formulation against Chikungunya Virus and Investigation of the Effects of Polyanions. J Pharm Sci. 2013 Dec;102(12):4305-14.

134. Krause PR, Bialek SR, Boppana SB, Griffiths PD, Laughlin CA, Ljungman P, Mocarski ES, Pass RF, Read JS, Schleiss MR, Plotkin SA. Priorities for CMV vaccine development. Vaccine. 2013 Dec 17;32(1):4-10.

135. Kristo AS, Kalea AZ, Schuschke DA, Klimis-Zacas D. Attenuation of alpha-adrenergic-induced vasoconstriction by dietary wild blueberries (Vaccinium angustifolium) is mediated by the NO-cGMP pathway in spontaneously hypertensive rats (SHRs). Int J Food Sci Nutr. 2013 Dec;64(8):979-87.

136. Laemmle-Ruff I, Barbaro B, Brotherton J. Human papillomavirus vaccine national catch-up program - Insights into under-notification. Aust Fam Physician. 2013 Dec;42(12):880-4.

137. Lambert ND, Haralambieva IH, Ovsyannikova IG, Larrabee BR, Pankratz VS, Poland GA. Characterization of humoral and cellular immunity to rubella vaccine in four distinct cohorts. Immunol Res. 2013 Dec 28. [Epub ahead of print].

138. Lee PI, Chen PY, Huang YC, Lee CY, Lu CY, Chang MH, Lin YZ, Chiu NC, Ni YH, Chen CM, Chang LY, Tang RB, Huang LM, Huang YF, Hwang KP, Hwang B, Lin TY. Recommendations for rotavirus vaccine. Pediatr Neonatol. 2013 Dec;54(6):355-9.

139. Li R, Huang L, Li J, Mo Z, He B, Wang Y, Wu X, Minutello M, Guinet-Morlot F, Pichon S. A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab(®) when administered  according to a post-exposure regimen in healthy children and adults in China. Vaccine. 2013 Dec 5;31(50):5940-7.

140. Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G, Kasturi S, Carlone GM, Quinn C, Chaussabel D, Palucka AK, Mulligan MJ, Ahmed R, Stephens DS, Nakaya HI, Pulendran B. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol. 2013 Dec 15. [Epub ahead of print].

141. Li SL, Lau YL, Lam TH, Yip PS, Fan SY, Ip P. HPV vaccination in Hong Kong: Uptake and reasons for non-vaccination amongst Chinese adolescent girls. Vaccine. 2013 Dec 2;31(49):5785-8.

142. Lin CJ, Zimmerman RK, Nowalk MP, Huang HH, Raviotta JM. Randomized controlled trial of two dosing schedules for human papillomavirus vaccination among college age males. Vaccine. 2013 Dec 13. [Epub ahead of print].

143. Linhares AC, Justino MC. Rotavirus vaccination in Brazil: effectiveness and  health impact seven years post-introduction. Expert Rev Vaccines. 2013 Dec 4. [Epub ahead of print].

144. Louzir H, Aoun K, Späth GF, Laouini D, Prina E, Victoir K, Bouratbine A.[Leishmania epidemiology, diagnosis, chemotherapy and vaccination approaches in the international network of Pasteur Institutes]. Med Sci (Paris). 2013 Dec;29(12):1151-60.

145. Lu PJ, Graitcer SB, O'Halloran A, Liang JL. Tetanus, diphtheria and acellular pertussis (Tdap) vaccination among healthcare personnel-United States, 2011. Vaccine. 2013 Dec 3. [Epub ahead of print].

146. Lu Y, Welsh JP, Swartz JR. Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines. Proc Natl Acad Sci U S A. 2013 Dec 16. [Epub ahead of print].

147. Luthy KE, Beckstrand RL, Asay W, Hewett C. Vaccinating parents experience vaccine anxiety too. J Am Assoc Nurse Pract. 2013 Dec;25(12):667-73.

148. Macdonald L, Cairns G, Angus K, de Andrade M. Promotional communications for influenza vaccination: a systematic review. J Health Commun. 2013 Dec;18(12):1523-49.

149. Macintyre CR, Heywood AE, Kovoor P, Ridda I, Seale H, Tan T, Gao Z, Katelaris AL, Siu HW, Lo V, Lindley R, Dwyer DE. Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study. Heart. 2013 Dec;99(24):1843-8.

150. Madsen LB, Ustrup M, Hansen KS, Nyasulu PS, Bygbjerg IC, Konradsen F. Estimating the costs of implementing the rotavirus vaccine in the national immunisation programme: the case of Malawi. Trop Med Int Health. 2013 Dec 9. [Epub ahead of print].

151. Maltezou HC, Fotiou A, Antonakopoulos N, Kallogriopoulou C, Katerelos P, Dimopoulou A, Tsoutsa V, Siahanidou T, Papagaroufalis C, Kostis E, Papantoniou N, Antsaklis A, Theodoridou M. Impact of postpartum influenza vaccination of mothers and household contacts in preventing febrile episodes, influenza-like illness, healthcare seeking, and administration of antibiotics in young infants during the 2012-2013 influenza season. Clin Infect Dis. 2013 Dec;57(11):1520-6.

152. Marsh HA, Malik F, Shapiro E, Omer SB, Frew PM. Message Framing Strategies to Increase Influenza Immunization Uptake Among Pregnant African American Women. Matern Child Health J. 2013 Dec 12. [Epub ahead of print].

153. Martínez-Baz I, Guevara M, Elía F, Ezpeleta C, Fernández Alonso M, Castilla J. [Influence of distinct criteria for selecting patients for swabbing on estimation of the effectiveness of the influenza vaccine.]. Gac Sanit. 2013 Dec 3. [Epub ahead of print].

154. McCarney S, Robertson J, Arnaud J, Lorenson K, Lloyd J. Using solar-powered refrigeration for vaccine storage where other sources of reliable electricity are inadequate or costly. Vaccine. 2013 Dec 9;31(51):6050-7.

155. McCarthy NL, Gee J, Lin ND, Thyagarajan V, Pan Y, Su S, Turnbull B, Chan KA, Weintraub E. Evaluating the safety of influenza vaccine using a claims-based health system. Vaccine. 2013 Dec 5;31(50):5975-82.

156. McCarthy NL, Irving S, Donahue JG, Weintraub E, Gee J, Belongia E, Baggs J. Vaccination coverage levels among children enrolled in the Vaccine Safety Datalink. Vaccine. 2013 Dec 2;31(49):5822-6.

157. McGrath LJ, Cole SR, Kshirsagar AV, Weber DJ, Stürmer T, Brookhart MA. Hospitalization and skilled nursing care are predictors of influenza vaccination among patients on hemodialysis: evidence of confounding by frailty. Med Care. 2013 Dec;51(12):1106-13.

158. McIntyre A, Zecevic A, Diachun L. Influenza Vaccinations: Older Adults' Decision-Making Process. Can J Aging. 2013 Dec 2:1-7. [Epub ahead of print].

159. McVoy MA. Cytomegalovirus vaccines. Clin Infect Dis. 2013 Dec;57 Suppl 4:S196-9.

160. McWhorter L, Gil-Rivas V. The Effect of Brief Functional Relaxation on College Students' Needle Anxiety During Injected Vaccinations. J Am Coll Health. 2013 Dec 7. [Epub ahead of print].

161. Meijboom MJ, Pouwels KB, Luytjes W, Postma MJ, Hak E. RSV vaccine in development: Assessing the potential cost-effectiveness in the Dutch elderly population. Vaccine. 2013 Dec 16;31(52):6254-60.

162. Michelim L, Medeiros GS, Zavascki AP. Current Status of Pseudomonas Aeruginosa Vaccine. Curr Pharm Biotechnol. 2013 Dec 26. [Epub ahead of print].

163. Miller PJ, Afonso CL, El Attrache J, Dorsey KM, Courtney SC, Guo Z, Kapczynski DR. Effects of Newcastle disease virus vaccine antibodies on the shedding and transmission of challenge viruses. Dev Comp Immunol. 2013 Dec;41(4):505-13.

164. Misstear K, McNeela EA, Murphy AG, Geoghegan JA, O'Keeffe KM, Fox J, Chan K, Heuking S, Collin N, Foster TJ, McLoughlin RM, Lavelle EC. Targeted Nasal Vaccination Provides Antibody-Independent Protection Against Staphylococcus aureus. J Infect Dis. 2013 Dec 29. [Epub ahead of print].

165. Mistry RD, Wedin T, Balamuth F, McGowan KL, Ellison AM, Nelson KA, McLoughlin RJ, Alpern ER. Emergency Department Epidemiology of Pneumococcal Bacteremia in Children Since the Institution of Widespread PCV7 Vaccination. J Emerg Med. 2013 Dec;45(6):813-20.

166. Moghaddasi S, Nouri-Majalan N, Masoumi R. The Effect of Adjuvant H1N1 Influenza Vaccine on Allograft Kidney Function. Transplant Proc. 2013 Dec;45(10):3508-10.

167. Monteiro MP. Obesity vaccines. Hum Vaccin Immunother. 2013 Dec 23;10(4). [Epub ahead of print].

168. Moriel DG, Schembri MA. Vaccination Approaches for the Prevention of Urinary Tract Infection. Curr Pharm Biotechnol. 2013 Dec 26. [Epub ahead of print].

169. Moro PL, Museru OI, Broder K, Cragan J, Zheteyeva Y, Tepper N, Revzina N, Lewis P, Arana J, Barash F, Kissin D, Vellozzi C. Safety of Influenza A (H1N1) 2009 Live Attenuated Monovalent Vaccine in Pregnant Women. Obstet Gynecol. 2013 Dec;122(6):1271-8.

170. Moyer CA, Tadesse L, Fisseha S. The relationship between facility delivery and infant immunization in Ethiopia. Int J Gynaecol Obstet. 2013 Dec;123(3):217-20.

171. Murhekar MV, Dutta S, Kapoor AN, Bitragunta S, Dodum R, Ghosh P, Swamy KK, Mukhopadhyay K, Ningombam S, Parmar K, Ravishankar D, Singh B, Singh V, Sisodiya  R, Subramanian R, Takum T. Frequent exposure to suboptimal temperatures in vaccine cold-chain system in India: results of temperature monitoring in 10 states. Bull World Health Organ. 2013 Dec 1;91(12):906-13.

172. Mvundura M, Kien VD, Nga NT, Robertson J, Van Cuong N, Tung HT, Hong DT, Levin C. How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization. Vaccine. 2013 Dec 23. [Epub ahead of print].

173. Nakano J, Marui A, Muranaka H, Masumoto H, Noma H, Tabata Y, Ido A, Tsubouchi H, Ikeda T, Sakata R. Effects of hepatocyte growth factor in myocarditis rats induced by immunization with porcine cardiac myosin. Interact Cardiovasc Thorac Surg. 2013 Dec 9. [Epub ahead of print].

174. Nan X, Kim J. Predicting H1N1 Vaccine Uptake and H1N1-Related Health Beliefs: The Role of Individual Difference in Consideration of Future Consequences. J Health Commun. 2013 Dec 19. [Epub ahead of print].

175. Nohynek H, Wichmann O, D Ancona F; VENICE National Gatekeepers. National Advisory Groups and their role in immunization policy-making processes in European countries. Clin Microbiol Infect. 2013 Dec;19(12):1096-105.

176. O'Connor D, Trück J, Lazarus R, Clutterbuck EA, Voysey M, Jeffery K, Pollard AJ. The effect of chronic cytomegalovirus infection on pneumococcal vaccine responses. J Infect Dis. 2013 Dec 2. [Epub ahead of print].

177. O'Grady KA, Chang AB, Grimwood K. Vaccines for children and adults with chronic lung disease: efficacy against acute exacerbations. Expert Rev Respir Med. 2013 Dec 2. [Epub ahead of print].

178. O'Ryan M, Stoddard J, Toneatto D, Wassil J, Dull PM. A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program. Drugs. 2013 Dec 12. [Epub ahead of print].

179. Odusanya OO, Kuyinu YA, Kehinde OA, Shafi F, François N, Yarzabal JP, Dobbelaere K, Rüggeberg JU, Borys D, Schuerman L. Safety and immunogenicity of 10-valent pneumococcal nontypeable Hemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2-dose catch-up regimens in the second year of life. Hum Vaccin Immunother. 2013 Dec 4;10(3). [Epub ahead of print].

180. Ohtake S, Arakawa T. Recombinant therapeutic protein vaccines. Protein Pept Lett. 2013 Dec;20(12):1324-44.

181. Oliveira DB, Assis FL, Ferreira PC, Bonjardim CA, de Souza Trindade G, Kroon EG, Abrahão JS. Group 1 Vaccinia virus Zoonotic Outbreak in Maranhao State, Brazil. Am J Trop Med Hyg. 2013 Dec;89(6):1142-5.

182. Oliveira Jde F, Boing AF, Waldman EA, Antunes JL. Ecological study on mortality from influenza and pneumonia before and after influenza vaccination in the Northeast and South of Brazil. Cad Saude Publica. 2013 Dec;29(12):2535-45.

183. Opel DJ, Heritage J, Taylor JA, Mangione-Smith R, Salas HS, Devere V, Zhou C, Robinson JD. The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics. 2013 Dec;132(6):1037-46.

184. Ovsyannikova IG, White SJ, Larrabee BR, Grill DE, Jacobson RM, Poland GA. Leptin and leptin-related gene polymorphisms, obesity, and influenza A/H1N1 vaccine-induced immune responses in older individuals. Vaccine. 2013 Dec 17. [Epub ahead of print].

185. Owen JL, Sahay B, Mohamadzadeh M. New generation of oral mucosal vaccines targeting dendritic cells. Curr Opin Chem Biol. 2013 Dec;17(6):918-24.

186. Ozaki T. Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program. Vaccine. 2013 Dec 9;31(51):6155-60.

187. Pakkanen SH, Kantele JM, Herzog C, Kantele A. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae. Vaccine. 2013 Dec 14. [Epub ahead of print].

188. Panatto D, Amicizia D, Tanzi E, Bianchi S, Frati ER, Zotti CM, Lai PL, Bechini A, Rossi S, Gasparini R. Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy? BMC Infect Dis. 2013 Dec 6;13:575.

189. Papadopoulou D, Sipsas NV. Comparison of national clinical practice guidelines and recommendations on vaccination of adult patients with autoimmune rheumatic diseases. Rheumatol Int. 2013 Dec 10. [Epub ahead of print].

190. Passmore E, Ferson MJ, Tobin S. EpiReview: Meningococcal disease in NSW, 1991-2011: trends in relation to meningococcal C vaccination. N S W Public Health Bull. 2013 Dec;24(2-3):119-24. doi: 10.1071/NB12121.

191. Patel HD, Roberts ET, Constenla DO. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: A decision tree model. Vaccine. 2013 Dec 9;31(51):6072-8.

192. Patil RR. Vaccine quality and safety: Scrutinizing the reported 3-fold increase in adverse effects following immunization (Aefi) in India. Hum Vaccin Immunother. 2013 Dec 3;10(3). [Epub ahead of print].

193. Paul P, Fabio A. Literature review of HPV vaccine delivery strategies: Considerations for school- and non-school based immunization program. Vaccine. 2014 Jan 9;32(3):320-6.

194. Periasamy M, Datta M, Kannapiran M, Ramanathan VD, Venkatesan P. Influence of Neonatal Bacilli Calmette-Guerin Vaccination and Environmental Mycobacteria in Sensitizing the Antimycobacterial Activity of Macrophages. Am J Med Sci. 2013 Dec 27. [Epub ahead of print].

195. Pinto CS, Nunes B, Branco MJ, Falcão JM. Trends in influenza vaccination coverage in Portugal from 1998 to 2010: effect of major pandemic threats. BMC Public Health. 2013 Dec 5;13(1):1130.

196. Pollard C, De Koker S, Saelens X, Vanham G, Grooten J. Challenges and advances towards the rational design of mRNA vaccines. Trends Mol Med. 2013 Dec;19(12):705-13.

197. Poolman JT, Peeters CC, van den Dobbelsteen GP. The history of pneumococcal conjugate vaccine development: dose selection. Expert Rev Vaccines. 2013 Dec;12(12):1379-94.

198. Quantin C, Benzenine E, Velten M, Huet F, Farrington CP, Tubert-Bitter P. Self-controlled case series and misclassification bias induced by case selection from administrative hospital databases: application to febrile convulsions in pediatric vaccine pharmacoepidemiology. Am J Epidemiol. 2013 Dec 15;178(12):1731-9.

199. Rafferty E, Duclos P, Yactayo S, Schuster M. Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: A systematic review. Vaccine. 2013 Dec 2;31(49):5798-805.

200. Rainey JJ, Sugerman D, Brennan M, Cadet JR, Ernsly J, Lacapère F, Danovaro-Holliday MC, Mubalama JC, Nandy R. Rapid monitoring in vaccination campaigns during emergencies: the post-earthquake campaign in Haiti. Bull World Health Organ. 2013 Dec 1;91(12):957-62.

201. Rasmussen SA, Watson AK, Kennedy ED, Broder KR, Jamieson DJ. Vaccines and pregnancy: Past, present, and future. Semin Fetal Neonatal Med. 2013 Dec 16. [Epub ahead of print].

202. Rattanapak T, Birchall J, Young K, Ishii M, Meglinski I, Rades T, Hook S. Transcutaneous immunization using microneedles and cubosomes: Mechanistic investigations using Optical Coherence Tomography and Two-Photon Microscopy. J Control Release. 2013 Dec 28;172(3):894-903.

203. Reed SG, Orr MT, Fox CB. Key roles of adjuvants in modern vaccines. Nat Med. 2013 Dec;19(12):1597-608.

204. Remiche G, Abramowicz M, Mavroudakis N. Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated to hereditary neuropathy with liability  to pressure palsies (HNPP) and revealed after influenza AH1N1 vaccination. Acta Neurol Belg. 2013 Dec;113(4):519-22.

205. Richman AR, Swanson RS, Branham AR, Partridge BN. Measuring North Carolina pharmacists' support for expanded authority to administer human papillomavirus vaccines. J Pharm Pract. 2013 Dec;26(6):556-61.

206. Ridda I, Gao Z, Macintyre CR. Attitudes, knowledge and perceptions towards whooping cough and pertussis vaccine in hospitalized adults. Vaccine. 2013 Dec 23. [Epub ahead of print].

207. Riedmann EM. Human Vaccines & Immunotherapeutics: News. Hum Vaccin Immunother. 2013 Dec 1;9(12). [Epub ahead of print].

208. Riffelmann M, Mohr J, Hellenbrand W, Wirsing von Koenig CH. Time since last vaccine dose in PCR-positive and PCR-negative children with suspected pertussis to monitor pertussis vaccine effectiveness. Eur J Clin Microbiol Infect Dis. 2013 Dec 1. [Epub ahead of print].

209. Riolo MA, King AA, Rohani P. Can vaccine legacy explain the British pertussis resurgence? Vaccine. 2013 Dec 2;31(49):5903-8.

210. Rouleau I, De Serres G, Drolet JP, Skowronski DM, Ouakki M, Toth E, Landry M, Ménard S, Gagnon R. Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine. Vaccine. 2013 Dec 5;31(50):5989-96.

211. Rouveix E, Greffe S, Dupont C, Gherissi Cherni D, Beauchet A, Sordet Guepet H, Gavazzi G, Gaillat J; Intergroupe Société de pathologie infectieuse de langue française/Société de gériatrie et gérontologie clinique (Spilf/SGGC). [Low vaccination coverage against influenza in elderly hospitalized in France]. Rev Med Interne. 2013 Dec;34(12):730-4.

212. Rowhani-Rahbar A, Fireman B, Lewis E, Nordin J, Naleway A, Jacobsen SJ, Jackson LA, Tse A, Belongia EA, Hambidge SJ, Weintraub E, Baxter R, Klein NP. Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children. JAMA Pediatr. 2013 Dec 1;167(12):1111-7.

213. Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, Kang I. 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host. Clin Infect Dis. 2013 Dec 4. [Epub ahead of print].

214. Rudnick W, Liu Z, Shigayeva A, Low DE, Green K, Plevneshi A, Devlin R, Downey J, Katz K, Kitai I, Krajden S, Ostrowska K, Richardson D, Richardson S, Sarabia A, Silverman M, Simor AE, Tyrrell G, McGeer A; Toronto Invasive Bacterial Diseases Network. Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011. Vaccine. 2013 Dec 2;31(49):5863-71.

215. Rustomjee R, Lockhart S, Shea J, Fourie PB, Hindle Z, Steel G, Hussey G, Ginsberg A, Brennan MJ. Novel licensure pathways for expeditious introduction of  new tuberculosis vaccines: A discussion of the adaptive licensure concept. Tuberculosis (Edinb). 2013 Dec 8. [Epub ahead of print].

216. Said MA, Haile C, Palabindala V, Barker N, Myers R, Thompson R, Wilson L, Allan-Martinez F, Montgomery J, Monroe B, Tack D, Reynolds M, Damon I, Blythe D.  Transmission of vaccinia virus, possibly through sexual contact, to a woman at high risk for adverse complications. Mil Med. 2013 Dec;178(12):e1375-8.

217. Sarkadi J. Varicella-zoster virus vaccine, successes and difficulties. Acta Microbiol Immunol Hung. 2013 Dec;60(4):379-96.

218. Scheifele DW, Ward BJ, Halperin SA, McNeil SA, Crowcroft NS, Bjornson G. Approved but non-funded vaccines: Accessing individual protection. Vaccine. 2013 Dec 24. [Epub ahead of print].

219. Schink T, Holstiege J, Kowalzik F, Zepp F, Garbe E. Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination. Vaccine. 2013 Dec 24. pii: S0264-410X(13)01742-8. [Epub ahead of print].

220. Schoeps A, Ouédraogo N, Kagoné M, Sié A, Müller O, Becher H. Socio-demographic determinants of timely adherence to BCG, Penta3, measles, and complete vaccination schedule in Burkina Faso. Vaccine. 2013 Dec 17;32(1):96-102.

221. Schoffelen T, Herremans T, Sprong T, Nabuurs-Franssen M, Wever PC, Joosten LA, Netea MG, van der Meer JW, Bijlmer HA, van Deuren M. Limited humoral and cellular responses to Q fever vaccination in older adults with risk factors for chronic Q fever. J Infect. 2013 Dec;67(6):565-73.

222. Schormann N, Banerjee S, Ricciardi R, Chattopadhyay D. Structure of the uracil complex of Vaccinia virus uracil DNA glycosylase. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Dec;69(Pt 12):1328-34.

223. Schuck-Paim C, Taylor R, Lindley D, Klugman KP, Simonsen L. Use of near-real-time medical claims data to generate timely vaccine coverage estimates in the US: The dynamics of PCV13 vaccine uptake. Vaccine. 2013 Dec 5;31(50):5983-8.

224. Schueneman AJ, Sugar EA, Uram J, Bigelow E, Herman JM, Edil BH, Jaffee EM, Zheng L, Laheru DA. Low Total Lymphocyte Count Is Associated with Poor Survival in Patients with Resected Pancreatic Adenocarcinoma Receiving a GM-CSF Secreting Pancreatic Tumor Vaccine. Ann Surg Oncol. 2013 Dec;20 Suppl 3:725-30.

225. Schönberger K, Kirchgässner K, Riedel C, von Kries R. Effectiveness of 2+1 PCV7 vaccination schedules in children under 2 years: A meta-analysis of impact studies. Vaccine. 2013 Dec 5;31(50):5948-52.

226. Settembre EC, Dormitzer PR, Rappuoli R. Bringing influenza vaccines into the 21st century. Hum Vaccin Immunother. 2013 Dec 30;10(3). [Epub ahead of print].

227. Shaghaghi M, Parvaneh N, Ostad-Rahimi P, Fathi SM, Shahmahmoodi S, Abolhassani H, Aghamohammadi A. Combined immunodeficiency presenting with vaccine-associated paralytic poliomyelitis: a case report and narrative review of literature. Immunol Invest. 2013 Dec 2. [Epub ahead of print].

228. Shah KV. A Case for Immunization of Human Papillomavirus (HPV) 6/11-Infected Pregnant Women With the Quadrivalent HPV Vaccine to Prevent Juvenile-Onset Laryngeal Papilloma. J Infect Dis. 2013 Dec 23. [Epub ahead of print].

229. Shelton RC, Snavely AC, De Jesus M, Othus MD, Allen JD. HPV vaccine decision-making and acceptance: does religion play a role? J Relig Health. 2013 Dec;52(4):1120-30.

230. Sherwin RL, Gray S, Alexander R, McGovern PC, Graepel J, Pride MW, Purdy J, Paradiso P, File TM Jr. Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia. J Infect Dis. 2013 Dec 1;208(11):1813-20.

231. Shevtsov A, Tarlykov P, Zholdybayeva E, Shevtsova E, Momynkulov D, Sytnik I, Karibaev T, Chsherbakov A, Momynaliev K. Draft Genome Sequence of the Live Vaccine Strain Brucella abortus 82. Genome Announc. 2013 Dec 26;1(6).

232. Sigurdardottir ST, Center KJ, Davidsdottir K, Arason VA, Hjalmarsson B, Elisdottir R, Ingolfsdottir G, Northington R, Scott DA, Jonsdottir I. Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children. Vaccine. 2014 Jan 9;32(3):417-24.

233. Singharoy A, Polavarapu A, Joshi H, Baik MH, Ortoleva P. Epitope fluctuations in the human papillomavirus are under dynamic allosteric control: a computational evaluation of a new vaccine design strategy. J Am Chem Soc. 2013 Dec 11;135(49):18458-68.

234. Slifka MK, Leung DY, Hammarlund E, Raué HP, Simpson EL, Tofte S, Baig-Lewis S, David G, Lynn H, Woolson R, Hata T, Milgrom H, Hanifin J. Transcutaneous yellow fever vaccination of subjects with or without atopic dermatitis. J Allergy Clin Immunol. 2013 Dec 9. [Epub ahead of print].

235. Smith A, Perelman M, Hinchcliffe M. Chitosan: A promising safe and immune-enhancing adjuvant for intranasal vaccines. Hum Vaccin Immunother. 2013 Dec 17;10(3). [Epub ahead of print]. Review.

236. Smith KJ. Determining the cost-effectiveness of adult pneumococcal vaccination strategies. Expert Rev Pharmacoecon Outcomes Res. 2013 Dec 16. [Epub ahead of print].

237. Smits K, Pottier G, Smet J, Dirix V, Vermeulen F, De Schutter I, Carollo M, Locht C, Ausiello CM, Mascart F. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination. Vaccine. 2013 Dec 17;32(1):111-8.

238. Song Y, Zhang X, Lu C, Zhang F, Zhu H. Progress in Development of Group A Streptococcus Vaccines. Curr Pharm Biotechnol. 2013 Dec 26. [Epub ahead of print].

239. Staltari O, Cilurzo F, Caroleo B, Greco A, Corasaniti F, Genovesi MA, Gallelli L. Annual report on adverse events related with vaccines use in Calabria (Italy): 2012. J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S61-5.

240. Stanisic DI, Barry AE, Good MF. Escaping the immune system: How the malaria parasite makes vaccine development a challenge. Trends Parasitol. 2013 Dec;29(12):612-22.

241. Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Vaccine. 2013 Dec 16;31(52):6232-8.

242. Stockwell MS, Westhoff C, Kharbanda EO, Vargas CY, Camargo S, Vawdrey DK, Castaño PM. Influenza Vaccine Text Message Reminders for Urban, Low-Income Pregnant Women: A Randomized Controlled Trial. Am J Public Health. 2013 Dec 19. [Epub ahead of print].

243. Sun W, Curtiss R. Rational Considerations about Development of Live Attenuated Y. Pestis Vaccines. Curr Pharm Biotechnol. 2013 Dec 26. [Epub ahead of print].

244. Suwantika AA, Postma MJ. Effect of breastfeeding promotion interventions on cost-effectiveness of rotavirus immunization in Indonesia. BMC Public Health. 2013 Dec 1;13(1):1106.

245. Svensson M, Ramelius A, Nilsson AL, Delli AJ, Larsson HE, Carlsson A, Forsander G, Ivarsson SA, Ludvigsson J, Kockum I, Marcus C, Samuelsson U, Ortqvist E, Lernmark A; The Better Diabetes Diagnosis (BDD) study group. Antibodies to influenza virus A/H1N1 hemagglutinin in type 1 diabetes children diagnosed before, during and after the Swedish A(H1N1)pdm09 vaccination campaign 2009-2010. Scand J Immunol. 2013 Dec 9. [Epub ahead of print].

246. Tatochenko V, Sidorenko S, Namazova-Baranova L, Mayanskiy N, Kulichenko T, Baranov A, Lobzin Y, Kharit S, Kozlov R, Andreeva I, Muravjev A, Chagaryan A, Koroleva I, Beloshitskiy G, Mironov K, Degtyareva E, Reinert RR. Streptococcus pneumoniae serotype distribution in children in the Russian Federation before the introduction of pneumococcal conjugate vaccines into the National Immunization Program. Expert Rev Vaccines. 2013 Dec 18. [Epub ahead of print].

247. Thomassen YE, van 't Oever AG, van Oijen MG, Wijffels RH, van der Pol LA, Bakker WA. Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals. PLoS One. 2013 Dec 12;8(12):e83374.

248. Thompson KM, Duintjer Tebbens RJ. National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradication. Expert Rev Vaccines. 2013 Dec 4. [Epub ahead of print].

249. Thompson MG, Li DK, Shifflett P, Sokolow LZ, Ferber JR, Kurosky S, Bozeman S, Reynolds SB, Odouli R, Henninger ML, Kauffman TL, Avalos LA, Ball S, Williams JL, Irving SA, Shay DK, Naleway AL; for the Pregnancy and Influenza Project Workgroup. Effectiveness of Seasonal Trivalent Influenza Vaccine for Preventing Influenza Virus Illness Among Pregnant Women: A Population-Based Case-Control Study During the 2010-2011 and 2011-2012 Influenza Seasons. Clin Infect Dis. 2013 Dec 19. [Epub ahead of print].

250. Thompson MG, Sokolow LZ, Almendares O, Openo K, Farley MM, Meek J, Ray J, Kirley PD, Reingold A, Aragon D, Hancock E, Baumbach J, Schaffner W, Lynfield R, Ryan P, Monroe M, Cheng PY, Fry AM, Shay DK. Effectiveness of nonadjuvanted monovalent influenza A(H1N1)pdm09 vaccines for preventing reverse transcription polymerase chain reaction-confirmed pandemic influenza hospitalizations: case-control study of children and adults at 10 US influenza surveillance network sites. Clin Infect Dis. 2013 Dec;57(11):1587-92.

251. Thyagarajan V, Su S, Gee J, Duffy J, McCarthy NL, Chan KA, Weintraub ES, Lin ND. Identification of seizures among adults and children following influenza vaccination using health insurance claims data. Vaccine. 2013 Dec 5;31(50):5997-6002.

252. Troy S, Ferreyra-Reyes L, Huang C, Sarnquist C, Canizales-Quintero S, Nelson C, Báez-Saldaña R, Holubar M, Ferreira-Guerrero E, García-García L, Maldonado Y. Community Circulation Patterns of Oral Polio Vaccine Serotypes 1, 2, and 3 after Mexican National Immunization Weeks. J Infect Dis. 2013 Dec 23. [Epub ahead of print].

253. Van Buynder PG, Konrad S, Van Buynder JL, Brodkin E, Krajden M, Ramler G, Bigham M. The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly. Vaccine. 2013 Dec 9;31(51):6122-8.

254. von Seidlein L, Bejon P. Malaria vaccines: past, present and future. Arch Dis Child. 2013 Dec;98(12):981-5.

255. Vázquez M. Safety of second-generation rotavirus vaccines, intussusception. Curr Opin Pediatr. 2013 Dec 11. [Epub ahead of print].

256. Wagner KS, van Wijgerden JC, Andrews N, Goulden K, White JM. Childhood vaccination coverage by ethnicity within London between 2006/2007 and 2010/2011. Arch Dis Child. 2013 Dec 17. [Epub ahead of print].

257. Wang X, Coleman HN, Nagarajan U, Spencer HJ, Nakagawa M. Candida skin test reagent as a novel adjuvant for a human papillomavirus peptide-based therapeutic vaccine. Vaccine. 2013 Dec 2;31(49):5806-13..

258. Warner JG, Portlock J, Smith J, Rutter P. Increasing seasonal influenza vaccination uptake using community pharmacies: experience from the Isle of Wight, England. Int J Pharm Pract. 2013 Dec;21(6):362-7.

259. Wasan SK, Calderwood AH, Long MD, Kappelman MD, Sandler RS, Farraye FA. Immunization Rates and Vaccine Beliefs Among Patients with Inflammatory Bowel Disease: An Opportunity for Improvement. Inflamm Bowel Dis. 2013 Dec 26. [Epub ahead of print].

260. Waye A, Jacobs P, Schryvers AB. Vaccine development costs: a review. Expert Rev Vaccines. 2013 Dec;12(12):1495-501.

261. Weinberger B, Schirmer M, Matteucci Gothe R, Siebert U, Fuchs D, Grubeck-Loebenstein B. Recall responses to tetanus and diphtheria vaccination are frequently insufficient in elderly persons. PLoS One. 2013 Dec 11;8(12):e82967.

262. Weinmann S, Chun C, Schmid DS, Roberts M, Vandermeer M, Riedlinger K, Bialek SR, Marin M. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009. J Infect Dis. 2013 Dec 1;208(11):1859-68.

263. WHO. Haemophilus influenzae type b (Hib) Vaccination WHO position paper July 2013-Recommendations. Vaccine. 2013 Dec 16;31(52):6168-9.

264. Wright JG, Plikaytis BD, Rose CE, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Semenova VA, Li H, Schiffer J, Dababneh H, Martin SK, Martin SW, Marano N, Messonnier NE, Quinn CP. Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: A randomized trial. Vaccine. 2013 Dec 24. [Epub ahead of print].

265. Wu Z, Cui F, Chen Y, Miao N, Gong X, Luo H, Wang F, Zheng H, Kane M, Hadler  SC, Hutin YJ, Liang X, Yang W. Evaluation of immunization injection safety in China, 2010: Achievements, future sustainability. Vaccine. 2013 Dec 27;31 Suppl 9:J43-8.

266. Xiao Y, Moghadas SM. Impact of viral drift on vaccination dynamics and patterns of seasonal influenza. BMC Infect Dis. 2013 Dec 13;13:589.

267. Xu H, Gao X, Bo F, Ma J, Li Y, Fan C, Jiang L, Ma Y, Luo H, An Z. A rubella outbreak investigation and BRD-II strain rubella vaccine effectiveness study, Harbin city, Heilongjiang province, China, 2010-2011. Vaccine. 2013 Dec 17;32(1):85-9.

268. Yang Z, Maruri-Avidal L, Sisler J, Stuart CA, Moss B. Cascade regulation of vaccinia virus gene expression is modulated by multistage promoters. Virology. 2013 Dec;447(1-2):213-20.

269. Yu Z, Reid JC, Yang YP. Utilizing dynamic light scattering as a process analytical technology for protein folding and aggregation monitoring in vaccine manufacturing. J Pharm Sci. 2013 Dec;102(12):4284-90.

270. Zeng C, Newcomer SR, Glanz JM, Shoup JA, Daley MF, Hambidge SJ, Xu S. Bias Correction of Risk Estimates in Vaccine Safety Studies With Rare Adverse Events Using a Self-controlled Case Series Design. Am J Epidemiol. 2013 Dec 15;178(12):1750-9.

271. Zenteno-Cuevas R. Update on the Development of TB Vaccines. Curr Pharm Biotechnol. 2013 Dec 26. [Epub ahead of print].

272. Zhang B, Liu Y, Wang X, Jiang L, Lu Z, Zhang X, Li K, Hu H. A novel recombinant Salmonella vaccine enhances the innate immunity of NK cells against acute myeloid leukaemia cells Kasumi-1 in vitro. Cell Biol Int. 2013 Dec;37(12):1320-9.

273. Zhao L, Seth A, Wibowo N, Zhao CX, Mitter N, Yu C, Middelberg AP. Nanoparticle vaccines. Vaccine. 2014 Jan 9;32(3):327-37.

274. Zhou N, Zhang Y, Zhang JC, Feng L, Bao JK. The receptor binding domain of MERS-CoV: The dawn of vaccine and treatment development. J Formos Med Assoc. 2013 Dec 13. [Epub ahead of print].

275. Zimmerman RK. Ethical analyses of institutional measures to increase health care worker influenza vaccination rates. Vaccine. 2013 Dec 16;31(52):6172-6.

276. Zuccotti G, Mameli C, Daprai L, Garlaschi ML, Dilillo D, Bedogni G, Faccini M, Gramegna M, Torresani E; For the PneuMi Study Group (PMSG). Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era. Vaccine. 2013 Dec 14. [Epub ahead of print].                                                                                                                                                            
[Top]